The Population Council collaborates with pharmaceutical companies to develop, manufacture, and distribute contraceptives and other products to the global market. In keeping with the Council’s mission, these partnerships include provisions to ensure that products are offered to people in less-developed countries at public-sector prices.
Through its Center for Biomedical Research, the Council has developed and licensed some of the most widely used long-acting, reversible contraceptives in the world. Currently, 170 million women worldwide are using a highly effective contraceptive developed by the Population Council or based on our technology, including the Copper T intrauterine device; Mirena®, the levonorgestrel-releasing intrauterine system; and the implants Jadelle® and Norplant®.